Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.68 |
| ▸ | ITGA4 | P13612 | 2/20 | 0.47 |
| ▸ | ITGB7 | P26010 | 2/20 | 0.47 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 4/20 | 0.42 |
| ▸ | PPARA | Q07869 | 4/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CTSS | P25774 | 2/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.41 |
| ▸ | MIF | P14174 | 1/20 | 0.40 |
| ▸ | ACE | P12821 | 1/20 | 0.39 |
| ▸ | MLYCD | O95822 | 1/20 | 0.39 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL548006 | 1.00 | AAK1 (0.68) | AAK1ITGA4ITGB7SLC7A5ATM | |
| SCHEMBL548007 | 1.00 | AAK1 (0.68) | AAK1ITGA4ITGB7SLC7A5ATM | |
| SCHEMBL29389786 | 0.92 | AAK1 (0.62) | AAK1ITGA4ITGB7SLC7A5ATM | |
| SCHEMBL30949483 | 0.92 | AAK1 (0.62) | AAK1ITGA4ITGB7SLC7A5ATM | |
| SCHEMBL12568248 | 0.92 | AAK1 (0.62) | AAK1ITGA4ITGB7PPARGPPARA | |
| SCHEMBL22033186 | 0.92 | AAK1 (0.62) | AAK1ITGA4ITGB7SLC7A5ATM | |
| SCHEMBL25319120 | 0.91 | AAK1 (0.61) | AAK1ITGA4ITGB7SLC7A5ATM | |
| SCHEMBL5981707 | 0.91 | AAK1 (0.61) | AAK1ITGA4ITGB7PPARGPPARA | |
| SCHEMBL18511393 | 0.91 | AAK1 (0.65) | AAK1ITGA4ITGB7SLC7A5ATM | |
| SCHEMBL977220 | 0.91 | AAK1 (0.61) | AAK1ITGA4ITGB7SLC7A5ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114768866-B | Chiral deuterated Maruoka phase transfer catalyst, preparation method thereof and application thereof in asymmetric catalytic reaction | 广东工业大学 | 2023-10-17 | — | — | CN | disclosed |
| CN-114768866-A | Chiral deuterated Maruoka phase transfer catalyst, preparation method thereof and application thereof in asymmetric catalytic reaction | 广东工业大学 | 2022-07-22 | — | — | CN | disclosed |
| CN-109689651-B | Novel chiral phase transfer catalyst and method for preparing alpha-amino acid by using same | 莫瓦斯有限责任公司 | 2022-04-26 | — | — | CN | disclosed |
| CN-111574450-B | Novel chiral biphenyl quaternary ammonium salt phase transfer catalyst and preparation method and application thereof | 广东工业大学 | 2021-10-29 | — | — | CN | disclosed |
| CN-111574450-A | Novel chiral biphenyl quaternary ammonium salt phase transfer catalyst and preparation method and application thereof | 广东工业大学 | 2020-08-25 | — | — | CN | disclosed |
| US-10696621-B2 | Chiral phase-transfer catalyst and method for preparing alpha-amino acid by using the same | UNIV YEUNGNAM RES COOPERATION FOUNDATION (KR) | 2020-06-30 | — | — | US | disclosed |
| US-20190292133-A1 | NOVEL CHIRAL PHASE-TRANSFER CATALYST, AND METHOD FOR PREPARING A-AMINO ACID BY USING SAME | UNIV YEUNGNAM RES COOPERATION FOUNDATION (KR) | 2019-09-26 | — | — | US | disclosed |
| EP-3459947-A1 | NOVEL CHIRAL PHASE-TRANSFER CATALYST, AND METHOD FOR PREPARING -AMINO ACID BY USING SAME | Research Cooperation Foundation of Yeungnam University (KR) | 2019-03-27 | — | — | EP | disclosed |
| EP-1854796-B1 | OPTICALLY ACTIVE AMMONIUM SALT COMPOUND, PRODUCTION INTERMEDIATE THEREOF AND METHOD FOR PRODUCING SAME | NIPPON SODA CO (JP) | 2016-05-04 | — | — | EP | disclosed |
| US-8962898-B2 | Optically active ammonium salt compound, production intermediate thereof, and production method thereof | NIPPON SODA CO., LTD. (JP) | 2015-02-24 | — | — | US | disclosed |
| US-8507669-B2 | Optically active dibenzazepine derivatives | NIPPON SODA CO., LTD. (JP) | 2013-08-13 | — | — | US | disclosed |
| US-8507669-B2 | Optically active dibenzazepine derivatives | NIPPON SODA CO., LTD. (JP) | 2013-08-13 | — | — | US | disclosed |
| US-20130131337-A1 | OPTICALLY ACTIVE AMMONIUM SALT COMPOUND, PRODUCTION INTERMEDIATE THEREOF, AND PRODUCTION METHOD THEREOF | NIPPON SODA CO., LTD. (JP) | 2013-05-23 | — | — | US | disclosed |
| US-8367820-B2 | Optically active ammonium salt compound, production intermediate thereof, and production method thereof | NIPPON SODA CO., LTD. (JP) | 2013-02-05 | — | — | US | disclosed |
| US-20110034688-A1 | OPTICALLY ACTIVE DIBENZAZEPINE DERIVATIVES | NIPPON SODA CO., LTD. (JP) | 2011-02-10 | — | — | US | disclosed |
| US-20110034688-A1 | OPTICALLY ACTIVE DIBENZAZEPINE DERIVATIVES | NIPPON SODA CO., LTD. (JP) | 2011-02-10 | — | — | US | disclosed |
| US-20100041881-A1 | OPTICALLY ACTIVE AMMONIUM SALT COMPOUND, PRODUCTION INTERMEDIATE THEREOF, AND PRODUCTION METHOD THEREOF | NIPPON SODA CO., LTD. (JP) | 2010-02-18 | — | — | US | disclosed |
| EP-1854796-A1 | OPTICALLY ACTIVE AMMONIUM SALT COMPOUND, PRODUCTION INTERMEDIATE THEREOF AND METHOD FOR PRODUCING SAME | Kyoto University (JP) | 2007-11-14 | — | — | EP | disclosed |
| WO-2003045948-A1 | NOVEL PHASE TRANSFER CATALYST AND METHOD FOR PRODUCING ALPHA-AMINO ACID USING THE SAME | AMINOGEN CO., LTD. (KR) | 2003-06-05 | — | — | WO | disclosed |
| WO-2002083670-A1 | NOVEL PHASE TRANSFER CATALYST AND METHOD FOR PRODUCING ALPHA-AMINO ACID USING THE SAME | AMINOGEN CO., LTD. (KR) | 2002-10-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292133-A1 | NOVEL CHIRAL PHASE-TRANSFER CATALYST, AND METHOD FOR PREPARING A-AMINO ACID BY USING SAME | BCAT1, AADAT, ATIC | AAK1 267/4885ITGA4 4286/4885ITGB7 3513/4885 |
| US-20110034688-A1 | OPTICALLY ACTIVE DIBENZAZEPINE DERIVATIVES | DRD1, DRD4, DRD2 | AAK1 1636/4885ITGA4 2224/4885ITGB7 895/4885 |
| US-10696621-B2 | Chiral phase-transfer catalyst and method for preparing alpha-amino acid by using the same | BCAT1, AADAT, CPN1 | AAK1 934/4885ITGA4 4449/4885ITGB7 3602/4885 |
| US-20100041881-A1 | OPTICALLY ACTIVE AMMONIUM SALT COMPOUND, PRODUCTION INTERMEDIATE THEREOF, AND PRODUCTION METHOD THEREOF | ASS1, ACSL3, AGT | AAK1 180/4885ITGA4 3221/4885ITGB7 830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.